You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

advanced Biliary Tract Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biliary Tract Carcinoma Trial in Beijing (Gemcitabine, S1, Tislelizumab)

Not yet recruiting
  • Biliary Tract Carcinoma
  • Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Apr 10, 2023

Biliary Tract Carcinoma Trial in Shanghai (Combination of Gemcitabine, Oxaliplatin, Donafenib and Tislelizumab)

Recruiting
  • Biliary Tract Carcinoma
  • Combination of Gemcitabine, Oxaliplatin, Donafenib and Tislelizumab
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 25, 2022

Biliary Tract Cancer Trial in Changchun (Lenvatinib, PD-1 inhibitors)

Recruiting
  • Biliary Tract Cancer
  • Changchun, Jilin, China
    Liu Bo
Aug 18, 2022

Advanced Biliary Tract Carcinoma Trial in Shanghai (Pembrolizumab Injection [Keytruda], Lenvatinib Mesylate)

Recruiting
  • Advanced Biliary Tract Carcinoma
  • Pembrolizumab Injection [Keytruda]
  • Lenvatinib Mesylate
  • Shanghai, Shanghai, China
  • +1 more
Jul 19, 2022

Advanced Biliary Tract Carcinoma Trial in Hangzhou (Camrelizumab, apatinib, gemcitabine, oxaliplatin, tegafur)

Not yet recruiting
  • Advanced Biliary Tract Carcinoma
  • Camrelizumab, apatinib, gemcitabine, oxaliplatin, tegafur
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
Jul 6, 2022

Biliary Tract Carcinoma Trial in Hershey (Abemaciclib)

Recruiting
  • Biliary Tract Carcinoma
  • Hershey, Pennsylvania
    Penn State Cancer Institute
Feb 3, 2022

Biliary Tract Carcinoma Trial in Shanghai (GP+PD-1+Tight)

Recruiting
  • Biliary Tract Carcinoma
  • Shanghai, China
    Zhongshan hospital
Mar 22, 2022

Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct Cancer Trial in Madison (Gemcitabine, Cisplatin, Zimberelimab)

Not yet recruiting
  • Biliary Tract Carcinoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin
Sep 15, 2023

Biliary Tract Tumors, Cholangiocarcinoma, Bile Duct Cancer Trial run by the NCI (Pembrolizumab (MK-3475), Oxaliplatin,

Completed
Has Results
  • Biliary Tract Neoplasms
  • +4 more
  • Pembrolizumab (MK-3475)
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 1, 2021

Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers Trial (ABBV-400)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • (no location specified)
Oct 10, 2023

HER2-positive Colorectal Cancer, HER2-positive Biliary Tract Cancer Trial in Beijing (KN026, KN046, XELOX)

Not yet recruiting
  • HER2-positive Colorectal Cancer
  • HER2-positive Biliary Tract Cancer
  • Beijing, State*, China
    Peking University cancer hospital & institution
Aug 2, 2023

Advanced Primary Liver Cancer, Advanced Biliary Tract Carcinoma Trial in Zhengzhou, Nanjing (SHR-1210, Apatinib, FOLFOX4)

Active, not recruiting
  • Advanced Primary Liver Cancer
  • Advanced Biliary Tract Carcinoma
  • SHR-1210
  • +3 more
  • Zhengzhou, Henan, China
  • +1 more
Apr 26, 2022

Biliary Carcinoma Trial in China (TQB3454 tablets, TQB3454 tablets matching )

Not yet recruiting
  • Biliary Carcinoma
  • TQB3454 tablets
  • TQB3454 tablets matching placebo
  • Beijing, Beijing, China
  • +5 more
Aug 4, 2023

Pancreatic Cancer, Hepatocellular Cancer, Biliary Tract Cancer Trial in Edmonton (Durvalumab, Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Durvalumab
  • +5 more
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Feb 1, 2023

Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial in

Not yet recruiting
  • Advanced Biliary Tract Carcinoma
  • +32 more
  • Biospecimen Collection
  • +6 more
  • Chicago, Illinois
    Northwestern University
Feb 6, 2023

Carcinoma, Hepatocellular, Biliary Tract Cancer, Secondary Liver Cancer Trial in Worldwide (RO7119929, Tocilizumab)

Completed
  • Carcinoma, Hepatocellular
  • +3 more
  • Duarte, California
  • +9 more
Jan 27, 2023

Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,

Active, not recruiting
Has Results
  • Advanced Bile Duct Carcinoma
  • +17 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 5, 2023

Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial

Not yet recruiting
  • Recurrent Biliary Tract Carcinoma
  • +13 more
  • (no location specified)
Nov 8, 2022

ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

Recruiting
  • ARID1A Gene Mutation
  • +15 more
  • Scottsdale, Arizona
  • +4 more
Dec 13, 2022

Advanced Biliary Tract Cancer, Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma Trial in Hangzhou (Irinotecan

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • +3 more
  • Irinotecan Liposome Injection
  • +3 more
  • Hangzhou, Zhejiang, China
    Cancer Hospital of the University of Chinese Academy of Sciences
Sep 16, 2021

Advanced Biliary Tract Carcinoma Trial in New York (Gemcitabine, Cisplatin, MEK162)

Completed
Has Results
  • Advanced Biliary Tract Carcinoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 26, 2020

Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +18 more
  • Clinical Encounter
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jul 24, 2023

Biliary Tract Carcinoma Trial in China (Pembrolizumab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Biliary Tract Carcinoma
  • Pembrolizumab
  • +3 more
  • Hefei, Anhui, China
  • +21 more
Aug 16, 2022

Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11

Recruiting
  • Advanced Solid Tumor
  • +24 more
  • MDNA11 Monotherapy
  • MDNA11 in combination with checkpoint inhibitor
  • Santa Monica, California
  • +7 more
Nov 1, 2022

Locally Advanced Biliary Tract Cancer, Metastatic Biliary Tract Cancer Trial in Guangzhou (Camrelizumab and Apatinib Plus GP)

Not yet recruiting
  • Locally Advanced Biliary Tract Cancer
  • Metastatic Biliary Tract Cancer
  • Camrelizumab and Apatinib Plus GP
  • Guangzhou, Guangdong, China
    Cancer center of SunYat-sen University
Feb 15, 2023